Using the 2 Stage Free Cash Flow to Equity, Artemis Gold fair value estimate is CA$31.17 The CA$19.72 analyst price target for ARTG is 37% less than our estimate of fair value How far off is ...

The trial evaluates THIO's safety, tolerability, and efficacy in combination with PD-(L)1 inhibition. THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who ...

Our Online Certificate Courses provide the expert knowledge and skills you need to enhance your career. From leadership and management, to finance and economics, to technology, law and public policy, ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo ® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The approval means that Libtayo is now the first immunotherapy approved in Europe to treat advanced cervical cancer, regardless of PD-L1 expression or tumour histology.

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

Artemis Gold Inc., a gold development company, focuses on the identification, acquisition, and development of gold properties. The company holds equity ownership interest in Velocity Minerals Ltd ...

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair. A new artificial intelligence (AI) model designed to ...